TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

South Korea · Delayed Price · Currency is KRW

788.00

-35.00 (-4.25%)

Feb 27, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
RF Business Division	12.77B	11.81B	12.40B	26.43B	24.43B
RF Business Division Growth	8.12%	-4.76%	-53.09%	8.20%	-49.47%
Pharmaceutical/Bio Business Division	26.87B	25.89B	16.49B	15.23B	13.02B
Pharmaceutical/Bio Business Division Growth	3.78%	57.05%	8.24%	16.99%	-8.03%
Other Sector	-	-	-	-	-1.21B
Elimination of Internal Transactions, Etc.	-1.78B	-1.40B	-1.06B	-3.82B	-3.10B
Total	37.87B	36.31B	27.83B	37.84B	33.14B
Total Growth	4.29%	30.46%	-26.46%	14.18%	-41.44%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	31.68B	30.21B	18.64B	20.00B	19.15B
South Korea Growth	4.85%	62.07%	-6.78%	4.39%	-27.69%
Asia	2.56B	2.86B	6.00B	14.88B	11.09B
Asia Growth	-10.70%	-52.27%	-59.68%	34.21%	-56.32%
North America	3.63B	3.23B	3.19B	2.97B	2.90B
North America Growth	12.37%	1.32%	7.54%	2.27%	161.56%
Total	37.87B	36.31B	27.83B	37.84B	33.14B
Total Growth	4.29%	30.46%	-26.46%	14.18%	-41.44%

Source: S&P Global Market Intelligence.